173 related articles for article (PubMed ID: 28971741)
1. Prognostic value of cryoglobulins, protein electrophoresis, and serum immunoglobulins for lymphoma development in patients with Sjögren's syndrome. A retrospective cohort study.
Kimman J; Bossuyt X; Blockmans D
Acta Clin Belg; 2018 Jun; 73(3):169-181. PubMed ID: 28971741
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic implications of mixed monoclonal cryoglobulinemia in Sjogren's disease].
Vasil'ev VI; Probatova NA; Varlamova EIu; Tupitsin NN; Simonova MV; Safonova TN; Bozh'eva LA; Shornikova NS; Logvinenko OA; Belenin GIu
Ter Arkh; 2004; 76(8):61-8. PubMed ID: 15471400
[TBL] [Abstract][Full Text] [Related]
3. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome.
Tzioufas AG; Boumba DS; Skopouli FN; Moutsopoulos HM
Arthritis Rheum; 1996 May; 39(5):767-72. PubMed ID: 8639173
[TBL] [Abstract][Full Text] [Related]
4. Cryoglobulinemia in autoimmune rheumatic diseases. Evidence of circulating monoclonal cryoglobulins in patients with primary Sjögren's syndrome.
Tzioufas AG; Manoussakis MN; Costello R; Silis M; Papadopoulos NM; Moutsopoulos HM
Arthritis Rheum; 1986 Sep; 29(9):1098-104. PubMed ID: 3489468
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.
Quartuccio L; Isola M; Baldini C; Priori R; Bartoloni Bocci E; Carubbi F; Maset M; Gregoraci G; Della Mea V; Salvin S; De Marchi G; Luciano N; Colafrancesco S; Alunno A; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
J Autoimmun; 2014 Jun; 51():75-80. PubMed ID: 24231556
[TBL] [Abstract][Full Text] [Related]
6. Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjögren's syndrome.
Baldini C; Ferro F; Luciano N; Bombardieri S; Grossi E
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):137-144. PubMed ID: 30156549
[TBL] [Abstract][Full Text] [Related]
7. Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjögren's syndrome : A long-term study of the Antonius Nieuwegein Sjögren (ANS) cohort.
Ter Borg EJ; Kelder JC
Rheumatol Int; 2017 Jul; 37(7):1153-1158. PubMed ID: 28424927
[TBL] [Abstract][Full Text] [Related]
8. Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors.
Brito-Zerón P; Ramos-Casals M; Bove A; Sentis J; Font J
Rheumatology (Oxford); 2007 Aug; 46(8):1359-62. PubMed ID: 17569749
[TBL] [Abstract][Full Text] [Related]
9. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome.
Ramos-Casals M; Brito-Zerón P; Yagüe J; Akasbi M; Bautista R; Ruano M; Claver G; Gil V; Font J
Rheumatology (Oxford); 2005 Jan; 44(1):89-94. PubMed ID: 15381790
[TBL] [Abstract][Full Text] [Related]
10. How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project).
Brito-Zerón P; Acar-Denizli N; Ng WF; Zeher M; Rasmussen A; Mandl T; Seror R; Li X; Baldini C; Gottenberg JE; Danda D; Quartuccio L; Priori R; Hernandez-Molina G; Armagan B; Kruize AA; Kwok SK; Kvarnström M; Praprotnik S; Sène D; Bartoloni E; Solans R; Rischmueller M; Suzuki Y; Isenberg DA; Valim V; Wiland P; Nordmark G; Fraile G; Bootsma H; Nakamura T; Giacomelli R; Devauchelle-Pensec V; Knopf A; Bombardieri M; Trevisani VF; Hammenfors D; Pasoto SG; Retamozo S; Gheita TA; Atzeni F; Morel J; Vollenveider C; Horvath IF; Sivils KL; Olsson P; De Vita S; Sánchez-Guerrero J; Kilic L; Wahren-Herlenius M; Mariette X; Ramos-Casals M;
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):102-112. PubMed ID: 30156539
[TBL] [Abstract][Full Text] [Related]
11. Hyperviscosity in primary Sjögren's syndrome: clinical implications.
Hernández-Molina G; Bermúdez-Bermejo P
Int J Rheum Dis; 2017 Jan; 20(1):84-89. PubMed ID: 26807556
[TBL] [Abstract][Full Text] [Related]
12. Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjögren's syndrome.
Tobón GJ; Saraux A; Gottenberg JE; Quartuccio L; Fabris M; Seror R; Devauchelle-Pensec V; Morel J; Rist S; Mariette X; De Vita S; Youinou P; Pers JO
Arthritis Rheum; 2013 Dec; 65(12):3218-27. PubMed ID: 23982978
[TBL] [Abstract][Full Text] [Related]
13. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome.
Solans-Laqué R; López-Hernandez A; Bosch-Gil JA; Palacios A; Campillo M; Vilardell-Tarres M
Semin Arthritis Rheum; 2011 Dec; 41(3):415-23. PubMed ID: 21665245
[TBL] [Abstract][Full Text] [Related]
14. [Mixed cryoglobulinaemia and benign monoclonal gammopathy in Sjogren's syndrome (author's transl)].
Clerc D; Segond P; Sallière D; Margulis J; Bisson M; Massias P
Sem Hop; 1980 Sep 8-15; 56(29-32):1290-2. PubMed ID: 6252617
[TBL] [Abstract][Full Text] [Related]
15. [The risk of lymphoma in Sjögren's syndrome].
Thieblemont C; Galicier L
Rev Prat; 2012 Feb; 62(2):232-3. PubMed ID: 22408872
[No Abstract] [Full Text] [Related]
16. Novel insights on lymphoma and lymphomagenesis in primary Sjögren's Syndrome.
Alunno A; Leone MC; Bartoloni E; Gerli R; Carubbi F
Panminerva Med; 2021 Dec; 63(4):491-498. PubMed ID: 33274907
[TBL] [Abstract][Full Text] [Related]
17. Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development.
Goules AV; Argyropoulou OD; Pezoulas VC; Chatzis L; Critselis E; Gandolfo S; Ferro F; Binutti M; Donati V; Zandonella Callegher S; Venetsanopoulou A; Zampeli E; Mavrommati M; Voulgari PV; Exarchos T; Mavragani CP; Baldini C; Skopouli FN; Fotiadis DI; De Vita S; Moutsopoulos HM; Tzioufas AG
Front Immunol; 2020; 11():594096. PubMed ID: 33193443
[TBL] [Abstract][Full Text] [Related]
18. Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren's syndrome: a retrospective clinical study.
Pollard RP; Pijpe J; Bootsma H; Spijkervet FK; Kluin PM; Roodenburg JL; Kallenberg CG; Vissink A; van Imhoff GW
J Rheumatol; 2011 Oct; 38(10):2198-208. PubMed ID: 21844152
[TBL] [Abstract][Full Text] [Related]
19. Sjögren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma.
Andonopoulos AP; Tiniakou M; Melachrinou M; Sfountouris H; Bounas A; Zervas C; Zoumbos NC
Rev Rhum Engl Ed; 1997 May; 64(5):287-92. PubMed ID: 9190001
[TBL] [Abstract][Full Text] [Related]
20. Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients.
Papageorgiou A; Ziogas DC; Mavragani CP; Zintzaras E; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
PLoS One; 2015; 10(2):e0116189. PubMed ID: 25723713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]